IGF1 and metastatic neoplasm: In patients with high biopsy GS (196 with localized and 49 with metastatic disease), serum IGF‐1 levels for those with localized and for those with metastatic disease were not significantly different (139.6 vs 130.8 ng/mL, P = 0.260).